Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

11075	Companies
243007	Keywords
171154	Articles
130792	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 03/22/2024 at 07:00, 2 years 6 months ago

Biophytis a présenté son protocole de phase 3 dans le traitement de la sarcopénie
Biophy's présente son protocole de phase 3 pour traiter la sarcopénie lors de l'ICFSR. L'étude SARA-31 évaluera l'efficacité de RuvembriTM. Biophytis recherche des partenaires pour le développement

Biophytis RuvembriTM Sarcopénie Biophy's Protocole De Phase 3
REGULATED PRESS RELEASE

published on 03/22/2024 at 07:00, 2 years 6 months ago

Biophytis presented its phase 3 protocol in the treatment of sarcopenia
Biophytis presents phase 3 protocol for sarcopenia treatment at ICFSR conference, showcasing the potential of RuvembriTM. CEO Stanislas Veillet seeks partners for drug development and financing

Biophytis RuvembriTM Clinical-stage Biotechnology Phase 3 Protocol Sarcopenia Treatment
BRIEF

published on 03/18/2024 at 07:05, 2 years 6 months ago

Biophytis annonce sa prochaine Assemblée Générale Mixte pour le 02 avril 2024

Biophytis Assemblée Générale Mixte Société Biotechnologique Vote Des Actionnaires Médicaments Vieillissement
BRIEF

published on 03/18/2024 at 07:05, 2 years 6 months ago

Biophytis Announces Combined General Meeting for April 2024

Biophytis RuvembriTM Clinical-stage Biotechnology Combined General Meeting Age-related Diseases
REGULATED PRESS RELEASE

published on 03/18/2024 at 07:00, 2 years 6 months ago

Assemblée générale mixte du 02 avril 2024
Assemblée générale mixte de Biophytis SA prévue le 02 avril 2024 à Paris. Actionnaires invités à voter en amont. Informations sur le site internet de la Société

Assemblée Générale Mixte Biophytis SA Vote Actionnaires Développement Médicaments Maladies Liées Au Vieillissement
REGULATED PRESS RELEASE

published on 03/18/2024 at 07:00, 2 years 6 months ago

Combined General Meeting of April 2, 2024
Biophytis SA will hold its Combined General Meeting (CGM) on April 2, 2024 at Sorbonne Université, Paris. Shareholders can vote in advance. The company specializes in developing therapies for age-related diseases

Therapeutics Combined General Meeting Biophytis SA Age-related Diseases CGM
BRIEF

published on 03/15/2024 at 23:05, 2 years 6 months ago

Biophytis met en œuvre le regroupement de ses actions pour réduire la volatilité

Marché Financier Biophytis Biotechnologie Regroupement D'actions Volatilité Du Titre
BRIEF

published on 03/15/2024 at 23:05, 2 years 6 months ago

Biophytis Announces Reverse Stock Split on Euronext Growth

Biophytis Biotechnology Shareholder Value Reverse Stock Split Euronext Growth
REGULATED PRESS RELEASE

published on 03/15/2024 at 23:00, 2 years 6 months ago

Biophytis annonce le lancement du regroupement des actions composant son capital social
Biophytis annonce le regroupement des actions de son capital social pour stabiliser l'action et favoriser son développement. Détails du regroupement et calendrier prévus

Euronext Growth Paris Actionnaires Biophytis Regroupement Des Actions Stabilisation
REGULATED PRESS RELEASE

published on 03/15/2024 at 23:00, 2 years 6 months ago

Biophytis announces the implementation of a reverse stock split of its ordinary shares traded on Euronext Growth
Biophytis implements a reverse stock split for its ordinary shares on Euronext Growth Paris and Nasdaq CM to stabilize share price. Details of the operation and key dates provided

Biophytis Reverse Stock Split Euronext Growth Nasdaq CM Share Price Stabilization

Accesswire

Published on 09/24/2026 at 14:55, 23 minutes ago

Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements
Published on 09/24/2026 at 14:30, 48 minutes ago

Solitario Resources CEO to Present at the 38th Annual Mining Forum Americas 2026 Conference
Published on 09/24/2026 at 14:00, 1 hour 18 minutes ago

Horizon Aircraft to Report First Quarter 2027 Results and Provide a Business Update on October 9, 2026
Published on 09/24/2026 at 14:00, 1 hour 18 minutes ago

Reeflex Completes $1.23 Million Goes Order on Schedule Ahead of Vancouver Investor Conference
Published on 09/24/2026 at 14:00, 1 hour 18 minutes ago

Nine Mile Metals DDH Wd-26-14 Intersects 5.09% Cu-Eq Over 14.15m Including 6.35% Cu-Eq Over 9m and 7.45% Cu-Eq Over 6m

View all ACCESSWIRE

EQS Group

Published on 09/24/2026 at 15:05, 12 minutes ago

Trustpilot Expands AI Discovery Suite With Dedicated Product Review Pages and New Brand Intelligence Tools
Published on 09/24/2026 at 15:05, 12 minutes ago

Ondo Launches Intelligent Portfolios, Powered by BlackRock, Bringing Portfolio Strategies Onchain
Published on 09/24/2026 at 15:05, 12 minutes ago

IPID Raises $16M as Instant Payments Expose a Growing Global Blind Spot
Published on 09/24/2026 at 14:47, 30 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 09/24/2026 at 14:47, 31 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc

Les Echos

Published on 09/24/2026 at 08:00, 7 hours 18 minutes ago

Neoen launches construction of 3 solar farms and a wind farm in France, with a total capacity of 101 MW
Published on 09/24/2026 at 08:00, 7 hours 18 minutes ago

Neoen lance la construction de trois parcs solaires et un parc éolien en France pour une capacité totale de 101 MW
Published on 09/24/2026 at 07:30, 7 hours 48 minutes ago

Gimv rondt met succes private plaatsing van een obligatie af voor een bedrag van EUR 150 miljoen
Published on 09/24/2026 at 07:30, 7 hours 48 minutes ago

Gimv successfully completes private placement of a bond for an amount of EUR 150 million
Published on 09/24/2026 at 07:30, 7 hours 48 minutes ago

Gimv successfully completes private placement of a bond for an amount of EUR 150 million

View all LES ECHOS COMFI WIRE